These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28600287)

  • 21. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.
    Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G
    J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.
    Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP
    Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
    Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y
    Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype.
    Kitamura K; Farber JM; Kelsall BL
    J Immunol; 2010 Sep; 185(6):3295-304. PubMed ID: 20720211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of regulatory T cells (T
    Aggarwal S; Sharma SC; N Das S
    J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.
    Oldham KA; Parsonage G; Bhatt RI; Wallace DM; Deshmukh N; Chaudhri S; Adams DH; Lee SP
    Eur Urol; 2012 Feb; 61(2):385-94. PubMed ID: 22079021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
    Xu L; Xu W; Qiu S; Xiong S
    Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
    Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
    Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.
    Lee JJ; Yeh CY; Jung CJ; Chen CW; Du MK; Yu HM; Yang CJ; Lin HY; Sun A; Ko JY; Cheng SJ; Chang YL; Chia JS
    PLoS One; 2014; 9(1):e85521. PubMed ID: 24465587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.
    Deng L; Zhang H; Luan Y; Zhang J; Xing Q; Dong S; Wu X; Liu M; Wang S
    Clin Cancer Res; 2010 Aug; 16(16):4105-12. PubMed ID: 20682706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
    Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
    J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway.
    Lian J; Liu S; Yue Y; Yang Q; Zhang Z; Yang S; Zhang Y
    Cancer Sci; 2021 Jan; 112(1):144-154. PubMed ID: 33113266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
    Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
    Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?
    Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.
    Xu L; Xu W; Wen Z; Xiong S
    PLoS One; 2011; 6(5):e20282. PubMed ID: 21655250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.